L-arginine to Reduce Sympathetic Nerve Activity in CKD Patients

Recruiting

L-ArginineL-arginine to Reduce Sympathetic Nerve Activity in CKD Patients

Sponsor:

The University of Texas at Arlington

Code:

NCT03982160

Conditions

Chronic Kidney Disease

Eligibility Criteria

Sex: All

Age: 35 - 70+

Healthy Volunteers: Not accepted

Interventions

L-Arginine

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-11-13. This information was provided to ClinicalTrials.gov by The University of Texas at Arlington on 2025-03-03.